Liang EC - Search Results

1

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.

Liang EC, Albittar A, Huang JJ, Hirayama AV, Kimble EL, Portuguese AJ, Chapuis A, Shadman M, Till BG, Cassaday RD, Milano F, Kiem HP, Riddell SR, Turtle CJ, Maloney DG, Gauthier J. Liang EC, et al. Blood Adv. 2023 Nov 28;7(22):6990-7005. doi: 10.1182/bloodadvances.2023011399. Blood Adv. 2023. PMID: 37774014 Free PMC article. Clinical Trial.

2

Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity.

Liang EC, Rejeski K, Fei T, Albittar A, Huang JJ, Portuguese AJ, Wu Q, Raj S, Subklewe M, Shouval R, Gauthier J. Liang EC, et al. Bone Marrow Transplant. 2024 Jul;59(7):910-917. doi: 10.1038/s41409-024-02278-3. Epub 2024 Apr 16. Bone Marrow Transplant. 2024. PMID: 38627450

3

Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients.

Kampouri E, Krantz EM, Xie H, Ibrahimi SS, Kiem ES, Sekhon MK, Liang EC, Cowan AJ, Portuguese A, Green DJ, Albittar A, Huang JJ, Gauthier J, Pérez-Osorio AC, Jerome KR, Zerr DM, Boeckh MJ, Hill JA. Kampouri E, et al. Among authors: liang ec. Blood. 2024 Aug 1;144(5):490-495. doi: 10.1182/blood.2024024145. Blood. 2024. PMID: 38635788

4

How I use next-generation sequencing-MRD to plan approach and prevent relapse after HCT for children and adults with ALL.

Muffly L, Liang EC, Dolan JG, Pulsipher MA. Muffly L, et al. Among authors: liang ec. Blood. 2024 Jul 18;144(3):253-261. doi: 10.1182/blood.2023023699. Blood. 2024. PMID: 38728375

5

Correction: Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity.

Liang EC, Rejeski K, Fei T, Albittar A, Huang JJ, Portuguese AJ, Wu Q, Raj S, Subklewe M, Shouval R, Gauthier J. Liang EC, et al. Bone Marrow Transplant. 2024 Nov 12. doi: 10.1038/s41409-024-02453-6. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39533017 No abstract available.

6

Development and validation of predictive models of early immune effector cell-associated hematotoxicity (eIPMs).

Liang EC, Huang JJ, Portuguese AJ, Ortiz-Maldonado V, Albittar A, Wuliji N, Basom R, Jeon Y, Wu QV, Torkelson A, Kirchmeier DR, Chutnik A, Pender BS, Sorror ML, Hill JA, Kopmar NE, Banerjee R, Cowan AJ, Green DJ, Gopal AK, Poh C, Shadman M, Hirayama AV, Till BG, Kimble EL, Iovino L, Chapuis AG, Otegbeye F, Cassaday RD, Milano F, Turtle CJ, Maloney DG, Gauthier J. Liang EC, et al. Blood Adv. 2024 Dec 3:bloodadvances.2024014455. doi: 10.1182/bloodadvances.2024014455. Online ahead of print. Blood Adv. 2024. PMID: 39626349

7

Next-generation sequencing-based MRD in adults with ALL undergoing hematopoietic cell transplantation.

Liang EC, Dekker SE, Sabile JMG, Torelli S, Zhang A, Miller K, Shiraz P, Hayes-Lattin B, Leonard JT, Muffly L. Liang EC, et al. Blood Adv. 2023 Jul 25;7(14):3395-3402. doi: 10.1182/bloodadvances.2023009856. Blood Adv. 2023. PMID: 37196642 Free PMC article.

8

T cell dysfunction and patient age are associated with poor outcomes after mechanical circulatory support device implantation.

Schaenman JM, Rossetti M, Korin Y, Sidwell T, Groysberg V, Liang E, Vangala S, Wisniewski N, Chang E, Bakir M, Bondar G, Cadeiras M, Kwon M, Reed EF, Deng M. Schaenman JM, et al. Hum Immunol. 2018 Apr;79(4):203-212. doi: 10.1016/j.humimm.2018.01.011. Epub 2018 Feb 1. Hum Immunol. 2018. PMID: 29409843 Free PMC article.

9

Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients.

Schaenman JM, Rossetti M, Sidwell T, Groysberg V, Sunga G, Korin Y, Liang E, Zhou X, Abdalla B, Lum E, Bunnapradist S, Pham T, Danovitch G, Reed EF. Schaenman JM, et al. Hum Immunol. 2018 Sep;79(9):659-667. doi: 10.1016/j.humimm.2018.06.006. Epub 2018 Jun 15. Hum Immunol. 2018. PMID: 29913200 Free PMC article.

10

Phase I study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult B-ALL patients.

Gauthier J, Liang EC, Huang JJ, Kimble EL, Hirayama AV, Fiorenza S, Voutsinas JM, Wu QV, Jaeger-Ruckstuhl CA, Pender BS, Kirchmeier DR, Torkelson A, Braathen K, Basom R, Shadman M, Kopmar NE, Cassaday RD, Riddell SR, Maloney DG, Turtle CJ. Gauthier J, et al. Among authors: liang ec. Blood Adv. 2025 Jan 16:bloodadvances.2024015314. doi: 10.1182/bloodadvances.2024015314. Online ahead of print. Blood Adv. 2025. PMID: 39820359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters